Certara Inc (NAS:CERT)
$ 13.29 0.29 (2.23%) Market Cap: 2.14 Bil Enterprise Value: 2.22 Bil PE Ratio: 0 PB Ratio: 2.05 GF Score: 83/100

Certara Inc at Piper Sandler Healthcare Conference (Virtual) Transcript

Nov 22, 2021 / 03:00PM GMT
Release Date Price: $28.79 (-5.54%)
Jeffrey Robert Garro
Piper Sandler & Co., Research Division - Senior Research Analyst

Hello, everyone, and welcome again to the Piper Sandler Healthcare Conference. We're really pleased today to have the executive team from Certara joining us. Specifically, we have William Feehery, the CEO; and Andrew Schemick, the CFO. So thank you again, guys, for joining us and making the time.

Questions & Answers

Jeffrey Robert Garro
Piper Sandler & Co., Research Division - Senior Research Analyst

And I'll just jump right into the questions. Maybe we'll start with a big picture view of the market opportunity. I would say from a macro level, there seems to be a lot of momentum to make drug discovery and development more efficient and effective. So I'd ask what major macro factors would you call out that are creating tailwinds specific to the adoption of biosimulation?

William F. Feehery
Certara, Inc. - CEO & Director

Yes. Thanks, Jeff. It's a great question. The #1 for us over the years has been the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot